Prevalence and multiple predictors of left atrial low voltage in paroxysmal and non-paroxysmal atrial fibrillation patients undergoing ablation: a systematic review and meta-analysis [0.03%]
阵发性和非阵发性心房颤动导管消融患者左心房低电压的患病率及多因素预测：系统评价和meta分析
Carlo-Agostino Oliva,Matteo Morello,Jordana Kron et al.
Carlo-Agostino Oliva et al.
Background and aims: In the left atrium (LA), low voltage areas (LVAs) detected at electroanatomic mapping in patients with atrial fibrillation (AF) are considered expression of atrial cardiomyopathy (AtCM). This meta-ana...
Outcomes of Left Atrial PFA With Low to Zero Fluoroscopy Utilisation for Atrial Fibrillation Treatment [0.03%]
低至零放射线利用的肺静脉前庭消融治疗房颤的疗效分析
Paul C Zei,David Newton,Devi Nair et al.
Paul C Zei et al.
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained [0.03%]
争议：射频消融后的空白期是必需的，并应维持
Helmut Pürerfellner,Stylianos Tzeis,John Mandrola
Helmut Pürerfellner
When Age Meets Genetics: Refining Heart Failure Risk Prediction in Young Atrial Fibrillation [0.03%]
当年龄遇到遗传学：年轻房颤患者的心力衰竭风险预测精化
Bin Deng,Wenhua Liu
Bin Deng
Another Day in FARADISE? Lessons learned from a Real-World Global Registry of Pulsed Field Ablation with the Pentaspline Catheter for Atrial Fibrillation Ablation [0.03%]
PARADISE再生？来自Pentaspline导管脉冲场消融阵发性和持续性房颤的全球注册中心的启示
Marco Schiavone,Luigi Di Biase
Marco Schiavone
Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry [0.03%]
Pentaspline脉冲场消融系统真实世界经验：FARADISE注册研究1年结果
Lucas V A Boersma,Gábor Széplaki,Antonio Dello Russo et al.
Lucas V A Boersma et al.
Aims: Clinical studies with protocol-mandated workflow and monitoring have analysed performance of pulsed field ablation (PFA) for treating atrial fibrillation (AF). The FARADISE registry captures global use of the pentas...
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trial [0.03%]
ARTESiA试验中阿哌沙班与阿司匹林用于检测到的高风险房颤患者减少血栓栓塞事件的成本效益分析
Andre Lamy,Roopinder K Sandhu,Wesley Tong et al.
Andre Lamy et al.
Background and aims: Apixaban was superior to aspirin for the prevention of stroke or systemic embolism in participants with subclinical atrial fibrillation (SCAF) in the Apixaban for the Reduction of Thrombo-Embolism in ...
Atrial arrhythmogenesis and electrophysiological remodeling in hypokalaemic metabolic syndrome: the role of apamin-sensitive SK channels [0.03%]
低钾代谢综合征心房 arrhythmogenesis 及电重构：Apamin 敏感的 SK 通道的作用
Chia-Hao Kuo,Jo-Yun Shih,Yi-Hsiung Lin et al.
Chia-Hao Kuo et al.
Aims: Metabolic syndrome (MetS) increases the risk of atrial arrhythmias (AA). Hypokalaemia, often secondary to diuretics or diet, frequently coexists with MetS and influences calcium handling. This study investigates the...
Two-year outcomes of left bundle branch area pacing versus traditional right ventricular pacing in middle-aged adults: a registry-based trial [0.03%]
中年人群左束支区域起搏与传统右心室起搏2年随访的注册登记研究
Matteo Bertini,Luca Canovi,Francesco Vitali et al.
Matteo Bertini et al.
Aims: Prolonged right ventricular pacing (RVP) increases the risk of cardiomyopathy, atrial fibrillation, heart failure (HF), and mortality. This registry-based trial compared left bundle branch area pacing (LBBAP) with R...
Randomized Controlled Trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2025 Aug 4;27(8):euaf181. DOI:10.1093/europace/euaf181 2025
Comprehensive Analysis of Desmosomal Protein Remodeling Identifies Desmocollin-2 as Potential Biomarker for Arrhythmogenic Cardiomyopathy [0.03%]
全面分析粘附蛋白重塑鉴定Desmocollin-2为致心律失常性心肌病潜在生物标志物
Jie Ren,Zhenliang Hu,Lingmin Wu et al.
Jie Ren et al.
Background and aims: Arrhythmogenic cardiomyopathy (ACM) is a genetically-determined disease characterized by malignant arrhythmias and sudden cardiac death, particularly in young individuals. Mutations in desmosomal gene...